(Q34621899)

3 August 2017

title

Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis (English)

1 reference

3 August 2017

1 reference

Kanehira M

1

1 reference

3 August 2017

Harada Y

2

1 reference

3 August 2017

Takata R

3

1 reference

3 August 2017

Shuin T

4

1 reference

3 August 2017

Miki T

5

1 reference

3 August 2017

Fujioka T

6

1 reference

3 August 2017

Nakamura Y

7

1 reference

3 August 2017

Katagiri T

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

23 April 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

26

1 reference

3 August 2017

issue

44

1 reference

3 August 2017

page(s)

6448-6455

1 reference

PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Conformational stability studies of the pleckstrin DEP domain: definition of the domain boundaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Medical applications of microarray technologies: a regulatory science perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Pleckstrin's repeat performance: a novel domain in G-protein signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Update on chemotherapy for advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

7 January 2021

The DEP Domain Determines Subcellular Targeting of the GTPase Activating Protein RGS9In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

7 January 2021

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

7 January 2021

Pleckstrin's repeat performance: a novel domain in G-protein signaling?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

7 January 2021

The treatment of advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

7 January 2021

Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210466

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210466

1 reference

Dimensions Publication ID

3 August 2017

1014302903

0 references

1 reference